Should a company be able to own the rights to something found inside your own body? In this episode, Chuck and Josh delve into the complicated, controversial world of gene patents. Tune in to learn more about the history -- and future -- of gene patents.
Learn more about your ad-choices at https://www.iheartpodcastnetwork.com
See omnystudio.com/listener for privacy information.
No summary for this episode yet.
This is an iHeart Podcast. Guaranteed human. Living with an autoimmune condition isn't easy, and every journey is different. That's why Season 5 of Untold Stories, Life with a Severe Autoimmune Condition, from Ruby Studio and Argenix, shares powerful firsthand stories from people with conditions like MG and CIDP. Hosted by Martine Hackett, these conversations dive into what resilience really looks like through setbacks, breakthroughs, and finding strength in community. Listen on the iHeart Radio app, Apple Podcasts, or wherever you get your podcasts. Banking with Capital One helps you keep more money in your wallet with no fees or minimums on checking accounts and no overdraft fees.
Just ask the Capital One Bank Guy. It's pretty much all he talks about, in a good way. He'd also tell you that this podcast is his favorite podcast too. Thanks, Capital One Bank Guy. What's in your wallet? Terms apply. See CapitalOne.com slash bank. Capital One N-A, member FDIC. Brought to you by the reinvented 2012 Camry. It's ready. Are you? Welcome to Stuff You Should Know from HowStuffWorks.com. Hey, and welcome to the podcast. I'm Josh Clark. This is Charles W. Chuck Bryant. This is William Shatner. You have the sound of a man who sounds like he's leaving town. I do. This comes up a lot.
A few short hours. Now that I think about it. It is a weekend. Yeah. I'm leaving town, too. Nice. Where are you going? I'm going to see my sister and my two nieces. Yeah. My brother-in-law's not there, but in Jacksonville, North Carolina. Very nice. At the U.S. Marine Corps base. Very nice. You're going to go to the PX? Camp Lejeune, I think. Sure. I'll go to the PX. You should get some stuff there. It's all at a military discount. Yeah, I'll buy some camo and ammo. Just walk like you're supposed to be in there. Maybe make eye contact with everybody, try to wither them, and they'll be like, oh, he's a soldier.
No, no. I always stand out like a sore thumb on the military basis. They're like, who's the fat hairy guy? Why is he here? And should I kill him? So are you excited? Yeah, I haven't seen my sister in a while. That's good. What about you? What you got going on? We are going to New York, you, me, and I, for a friend's wedding. Great. Two friends' wedding, two male friends' wedding. Hey. Yeah. Awesome. And it's official now. Congratulations to those guys. Yeah. Mitch and Patrick, our friends on the Facebook page tried to help them out. They were in a contest for Crate and Barrel wedding soup steaks.
Yeah. And a lot of people showed up and bumped them from number 20 something to number one for a little while. And then they just got crushed. So hats off to everybody on our Facebook page who helped them out. They are very grateful. And huzzah to them. Yes. Huzzah. Indeed. Best wishes from Stuff You Should Know from Mitch and Patrick, eh? Absolutely. Okay, so Chuck, you want to get down to this? Yes, how Gene Simmons works. Or Gene Shallot. Gene Ween. Gene Siskel. Gene Krupa. We'll end with Gene Krupa. Okay. Gene Patent really is what we're talking about, right? Yes. Very interesting. I agree.
Interesting and terrifying. Yeah. And by the way, I just want to go ahead and say that there is a documentary, a companion documentary, that's required viewing for this one. It's called The Corporation. If you have Netflix, it's streaming on Netflix. You can also order the DVD or whatever, but you could watch it literally right this second. It's probably all over YouTube, too. It's like one of those docs. Yeah. Very well made. Good stuff. I still haven't seen that. It touches on a lot of stuff in here and just goes into greater depth. So I say check out The Corporation. It's a good documentary either way.
But let me give you a little story here. All right. There is a condition. It can be congenital. It can actually be acquired, strangely enough, although I didn't find out how. But it's called growth hormone deficiency, right? Okay. And basically, it just means that you are short. You're smaller in stature than is average, right? Sure. Maybe you're smaller than the rest of your family members. Who knows? But the point is your pituitary glands aren't producing enough growth hormone. Is that like Emmanuel Lewis? I imagine that he has some sort of growth hormone deficiency. I think it's an umbrella term.
But yes. The good thing is it's treatable, and it's been treatable for a while, and we knew for a very long time where to get the treatment, where to get human growth hormone. And that was extracting it from the pituitary glands of cadavers. Cool. Up until the 70s, if you had growth hormone deficiency and you were given injections, the stuff they were injecting you with was extracted from cadaver's pituitary glands. But it was still good to go? It was. It worked, yeah. Wow. But it was very, very expensive. I mean, the extraction process, getting your hands on a dead body. Sure. I mean, there's a lot of factors involved.
And then until the 1980s, when a company called Novo Nordisk got a patent for a product called Nanormon. Yeah. It's just a mouthful that it had created in 1973, but it didn't get a patent until 1982. Couldn't they just call it Go Juice? Yeah. You know, or Grow Juice? That would be much more appropriate. Right. Okay. We'll figure that out later. So the history, to me, is one of the most interesting parts here. We'll get to 1982, which was a landmark year in this field. But let's back up, Josh. Yes. Let's use the Wayback Machine because we haven't done that in a while. Oh, wow. It has been a while.
There's a cobweb in here. There is. Ooh, it's musty. Somebody's been eating cheese, too. Yeah, there's like wrappers here. Processed cheese. Interesting. So let's go back in time. There were three rulings over the years starting in 1853 that sort of led to what we're talking about. But they weren't consistent. They sort of flip-flopped on the subject. In 1853, Robert Morse of the Telegraph fame was initially denied his patent because part of it involved electromagnetism, a key part of it. Right. And they said, you can't patent electromagnetism. No. Why? Silly boy. Because it's a principle of nature.
Right. It's like my device uses that cloud right there, so I'm going to patent that cloud. Right. Like you can't patent a cloud. Well, what about the process that makes clouds? No, you can't. It's nature. That's natural. You can't patent nature. And this is back when the U.S. Patent Office was the God-fearing U.S. Patent Office, and they knew what to issue patents for and what not to. Not the crazy, cuckoo, mixed-up patent office of today. That's right, where you can patent thoughts and dreams. Might as well. I'm patenting you, Chuck. I actually own that already. Oh, okay. And you owe me $10 for even saying that.
God. So following that, the second ruling in 1912, another court ruled that you could patent adrenaline because it's a distilled type of adrenaline that was treated in a lab outside the body, and it was different than the natural adrenaline inside the body. Right. Then after World War II, another ruling reversed it again, and the Supreme Court said, I'm sorry, you cannot patent this mixture of bacteria that you're making in your lab. Right. Because that's a living thing. Even though it doesn't exist in nature. Yeah. And this would later become a real touchstone in this argument. Like, does this exist in nature?
Like, that cloud right there. Sure. It's natural. You can't patent it. Right. But could you patent a process or a cloud that you can create in the lab that nature doesn't produce and maybe isn't capable of producing? That's where it gets hairy. Yeah. You know, everyone living with a rare autoimmune condition has their own story to tell. And that's why in Season 5 of Untold Stories, Life with a Severe Autoimmune Condition, a Ruby Studio production, in partnership with Argenix, you'll hear powerful, real-life perspectives. That's right. This podcast explores stories of what life is really like with MG or CIDP.
Host Martine Hackett sits down with people who faced it all. The early signs and symptoms, the search for answers, and the strength it takes to keep moving forward. Yeah, and this season the stories go even deeper, showing us what resilience truly looks like through setbacks, breakthroughs, and the communities that make all the difference. So listen to Untold Stories, Life with a Severe Autoimmune Condition, on the iHeartRadio app, Apple Podcasts, or wherever you get your podcasts. attention parents and grandparents if you're looking for a gift that's more than just a toy give them something that inspires confidence and adventure all year long give them a guardian bike the easiest safest and number one kids bike on the market yeah with usa made kids specific frames and patented safety technology kids are learning to ride in just one day with no training wheels needed.
It's why Guardian is America's favorite kids bike and the New York Times and Wirecutter's top pick three years in a row. That's right. My daughter has a Guardian bike and she loves it. And that thing was really easy to put together. And get this, this holiday season, Guardian is offering their biggest deal of the year, over 40% in savings on all bikes, plus $100 in free accessories. Guardian bikes have become one of the most sought after gifts of the season and inventory is going fast. So don't wait. Join over a half a million families who've discovered the magic of Guardian. Visit guardianbikes.
com to shop now. Another big step forward was the Plant Patent Act of 1930. Yeah. Thanks to a dude named Luther Burbank, which is a pretty rocking name. It is. That's my new hotel name. Luther Burbank. Yeah. It's pretty cool for a, you know, early 20th century white dude. Yeah. He was a botanist and he created more than 800 strains and varieties of plants, including the Shasta Daisy, the Fire Poppy, and the White Blackberry. I'm a fan of the Shasta Daisy. Yeah? Yeah. Thank you, Luther Burbank. We have Luther Burbank to thank. I see him wearing four-fingered rings. Oh, yeah. That says Luth. Yeah.
Or Shasta. So he was obviously pretty inspired to create plants, and they said, you know what? That's pretty neato that you can do all this stuff, so you should be allowed to. We're going to pass this plant act. But don't even try to patent bacteria. Again, there's a problem with bacteria that the court has always traditionally disallowed. Apparently, they consider bacteria more natural life than a hybrid plant. It's true, because of the next case. And that plant patent act, really, that is a big deal, even just beyond what we're talking about. Yeah. And we'll get to that later, like what effects that that has had.
Siege. Yeah. Yeah. And then there was also a Plant Protection Act of 1970 that also allowed patents as well. But again, this allowed bacteria. Bacteria keeps getting kicked around, kicked around, kicked around. Yeah. Until 1980, right? Was that Diamond v. Chakrabarty? Yeah. Yes. Ananda Shakraborty worked for GE, developed a bacterium that could break down crude oil, and said, hey, we should use this for oil spills. Yeah, very useful. Great idea. The Court of Customs and Patent Appeals, I'm sorry, it was initially rejected, and then the Customs and Patent Appeals Office overturned that, saying that the fact that it's alive has no significant purpose in our patent office.
Right. And also you left out that Chakrabody created a bacteria that didn't exist in nature. Oh, it was brand new? It was recombinant. He made it himself. That's pretty cool. Yes. But then the Supreme Court. He was God to this bacteria. Right. The Supreme Court then argued the case. And in 1980, Warren Burger wrote that whoever invents, and this is very key moving forward, whoever invents or discovers any new and useful process, machine, manufacturer, or, and this is the key, composition of matter, or any new and useful improvement thereof may obtain a patent, therefore subject to the blah, blah, blah, blah, blah.
Ergo, ipsum facto. But composition of matter is the key three words there. Right. There's a big difference between a product of nature or a principle of nature and the composition of matter, which could be anything from using two types of metal to create an alloy or insulin creating two types of dna to create yeah something like insulin um and by the way diamond in diamond v chakra body is diamond was the um the head of the patent's office so when you fought against it yeah he's he sued him to be like no this is this is wrong wouldn't you feel like you're in trouble if the if the head of the patent's office was suing you yeah like it It just seems worse, you know.
But he won. Sidney Diamond. And that changed everything. Within two years, the first patent for, the first gene patent, what we would call a gene patent, was issued to the University of California. Go Bears. Yeah, for a hormone engineered to, I guess, for milk production? I'm not sure. I know it was involved in breast cancer treatment, but I don't know exactly what it did. I got you. And then the same year, insulin was patented, recombinant insulin. Which was huge. Also, so that was the same year that Novo Nordisk got its patent for Nanormon. Nanormon. So clunky. The human growth hormone product.
Yeah. So that really just kind of opened up the floodgate. Chakrabody changed everything. And that shows up in the corporation, too. It's pretty interesting how they talk about that. Oh, really? But really, I guess as far as gene patents go, the real moment when everything changed was in the late 90s when this little-known group at the time popped up in the media and said, hey, we're almost finished entirely mapping the human genome. And the U.S. Patent Office workers went, eat. and there's a flood of patent requests, right? One was for Pandora Radio. Right, yeah. Wasn't that based on that, the Music Genome Project?
Was it? I think so. I would imagine if that's what they called it. Or inspired by it, at least. Right. But, yeah, everyone lined up all of a sudden was like, ooh, patent this, patent that, patent that. They'd be like, I heard about this gene, I want to patent it. I want to patent this one. And so they were inundated with it. So in 2001, the U.S. Patent and Trademark Office, the USPTO, issued new guidelines saying, okay, yes, anybody can apply for a patent, but you have to know what you're talking about. You have to know what the gene does, or you have to come up with some process using this gene.
There has to be criteria, everybody. A credible use. Yeah, there has to be criteria. Sure. And that definitely allowed some of the high – there was a high watermark and the tide ebbed a little bit. A little bit. But currently, I believe, which was the initial stat, there are 3,000 to 5,000 human gene patents right now. In the U.S. alone. Yeah, 47,000 involving inventions like equipment involving genetic material. Or insulin is another example. Yeah, true. It's an invention using genetic material. But there are more than 3 million on file as applicants. Yeah, like patent pending. Sure. Yeah. So, and that's with the tide ebbing.
I hope it's ebbing. And I think that's just in the United States again. isn't it? Yeah. In the United States, there's plenty in Europe and Japan. It's basically Europe, Japan, and the US are the leaders in issuing patents for this kind of stuff. Basically, if you want to push the rest of the world around, you go get a patent at one of these areas, patent offices. Right. So let's talk specifically about the US, right? Let's talk patents. Yeah. If you want to get a patent, You have to meet some criteria. It doesn't matter what the patent's for, whether it's for the dippy bird or for human growth hormone.
And so for any invention to get a patent, to be approved for a patent, it has to meet four criteria, right? It has to be useful. It has to be non-obvious, right? Like it can't be a shoestring? I don't know. What would an obvious one be, I wonder? An obvious invention would be, man, I don't know. I'm just curious. Maybe using peppermint to fight bad breath. Maybe. So obvious. Yeah, it's obvious. Sure. Anybody can do that. You can't patent that. There you go. There's our non-obvious example. It has to be novel, right? Yeah, sure. and it has to meet the enablement criterion, which is a big deal.
And this is pretty much the whole reason patents exist, one of the big reasons. Yeah, it's got to have detail. It can't be just a big, broad, esoteric thing. It's got to be detailed enough where someone in that field can figure it out and use it. Right. And this is one of the major reasons the patent office exists. It's to say, okay, thank you for sharing your findings with the rest of the world. We're going to give you 20 years of exclusivity. But in return, you're being totally transparent. Here's all of the process. Here's all the notes. Here's anything that anybody working in your field can look at and use to build upon your research.
Or gank it. But they have to pay you. Well, but can they gank it and change it enough to where it doesn't apply anymore? You can, and those are called patent trolls. And apparently, they're a big problem right now. Really? They're thwarting technology. I think Tech Stuff did something on patent trolls recently. Interesting. Yeah. and the strength it takes to keep moving forward. Yeah, and this season, the stories go even deeper, showing us what resilience truly looks like through setbacks, breakthroughs, and the communities that make all the difference. So listen to Untold Stories, Life with a Severe Autoimmune Condition, on the iHeartRadio app, Apple Podcasts, or wherever you get your podcasts.
Attention parents and grandparents. If you're looking for a gift that's more than just a toy, give them something that inspires confidence and adventure all year long. Give them a Guardian bike, the easiest, safest, and number one kid's bike on the market. Yeah, with USA-made kid-specific frames and patented safety technology, kids are learning to ride in just one day with no training wheels needed. It's why Guardian is America's favorite kid's bike and the New York Times and Wirecutter's top pick three years in a row. That's right. My daughter has a Guardian bike, and she loves it, and that thing was really easy to put together.
And get this, this holiday season, Guardian is offering their biggest deal of the year, over 40% in savings on all bikes, plus $100 in free accessories. Guardian bikes have become one of the most sought-after gifts of the season, and inventory is going fast, so don't wait. Join over a half a million families who've discovered the magic of Guardian. Visit guardianbikes.com to shop now. So if you are issued a patent, you get 20 years of exclusivity. Yeah. Nobody can use it, market it, sell it, anything that has to do with your invention or process, unless they pay you. They have to go through you, and you license it and reap the benefits, right?
Yeah, and the reason it was such a mad rush when the genome project was first completed, because obviously the first person to invent something gets the patent. So if you can prove that, then that's yours for 20 years. Well, that's based on the first to invent principle. Yeah, exactly. So you have to prove that, and then after that, you've got it for 20 years, and everyone was in a big rush to be the first with these gene patents. Have you heard the story of Alexander Graham Bell and Elijah, what was his name? You mean the real guy who invented the telephone? Yeah, what's his name? Oh, is that the case?
I knew there was some stink there, but I wasn't sure. Elijah Gray. apparently Elijah Gray invented a telephone that looked and worked way, way more like the ones we use today it was a cell phone actually the ones we used in the 70s and 80s it wasn't a cell phone but you know, the kind, the rotary dial, all that but Alexander Graham Bell beat him to the patent office yeah now did he steal his ideas or was it just concurrent? I think it was independent I can't remember what that's called But there's an idea that, oh, the zeitgeist. Ideas kind of float out there for anybody to latch onto, and sometimes people do independently.
I wonder how far apart they were from each other in being completed. I wonder if it was literally like my horse fell sick that day and I couldn't make it to the office, but Bell did. I don't remember how close it was. I'm sure it wasn't that close. It was pretty close. So the patent office has this first to invent principle where it's not necessarily like who beat who to the patent office. It's if you have a situation like that, who's been working on this longer or who reached a landmark longer? And then that's who gets the patent. Yeah. That's why there was, like you said, that mad rush because, you know, it's like, oh, I noticed this first.
So let me go ahead and get my patent in. Well, and with the case of insulin or any of these gene patents, really, you can't just say, oh, I got this thing. They have to have it on file, which is something I never knew. There are 26 culture depositories around the world thanks to, and this is such a mouthful, thanks to the Budapest Treaty on the International Recognition of the Depositive Microorganisms for the Purpose of Patent Procedure. So basically, it's like a repository where you send in your sample, right? Yeah. Isn't that the way I understand it? Right. And there's 26 of them worldwide, right?
Yeah, and if it is a product of – if it's something you remove from the body and process, the patent only applies to the very end result that you send in. Right. Not like the little stages along the way. Although you can patent those stages. Yeah, but they just have to be independent of one another. Right. Yeah. All right, so you've submitted your sample to a depository. You have applied for the patent. It's been issued. You're good to go. What are you patenting? I think there's a huge misunderstanding among the public that you're walking around and some company owns the rights to your jeans.
True or false? False. That is false. Okay. I mean, a gene patent is kind of a misnomer. It's a pretty big misnomer, actually, because there's certain criteria that have to be met. Like, you have natural, what is it, natural matter? Mm-hmm. Is that what it's called? Or something of nature? Composition of nature. Yeah, yeah, yeah. Genes are a composition of nature in your body. To patent something, you have to extract genes and get them to do, like, you know, jump through a flaming hoop outside of the body. then you have something called composition of matter. Yeah. Right? Yeah. So what are some of the things that people are getting gene patents for?
Well, it breaks down, my friend, into four categories pretty much. You want to go one at a time? Yeah. For a change? Diagnostics. That means they're looking to patent a method, basically. Generally, it tests for genetic differences, abnormalities, spotting genetic markers in cancer, Alzheimer's, stuff like that. Right. Pretty nice way to use your time, I think. It is, but it's also very controversial, as we'll see in a little bit. Well, not all of it is, but three of the four are. Right. And with diagnostics, what you're patenting is, in fact, the gene that you're looking at or the genes involved.
Yeah. And the mutations, right? So you have a bunch of different possible mutations for cancer. That's a complication for sure. Right. But a very sharp company. And by the way, by saying you need to know what you're talking about or you need to put some sort of research into this, basically excluded schmoes like you and I from getting gene patents and just said huge laboratories, huge corporations are the only ones who can possibly get gene patents now. Yeah. So if you have a very sharp laboratory or a very sharp corporation, they're going to have a patent for every possible mutation for a specific gene.
And then ultimately what they're patenting is the screening process, the test kit. Yeah, exactly. Used to evaluate these mutations. So that's number one. Functional use is the second. That is pretty much just discovering roles played by genes. They're usually issued for drugs that affect the functioning of the genes. Yeah. So I guess insulin would be that? No. Insulin is composition of matter. Okay. So functional use would be like, we understand that this mutation on this gene causes this to happen. So we're going to create a drug that makes the gene act normally, express normally. Right. Something like that.
And that's the future of pharmaceuticals is genetically tailored drugs. because right now when you take a drug, right, Tylenol or something, you're just throwing something in the wind and hoping it works, right? With genetically tailored drugs, it's like they'll look at your genetic composition and then say, well, this is the drug you need, and it will work 98% of the time. Right. And it will work 100% effectively, 98% of the time. $100,000, please. Make a check out to Merck. Exactly. Process is the third type of patent in this category, and that's pretty easy. That's basically protecting a method by which the genes are extracted or manipulated, and it's the least controversial out of all these because it's a more traditional kind of patent.
Right. This is like science. Yeah. And then you have composition of matter. That's the big one. Yeah, composition of matter and diagnostics are the two most controversial. And composition of matter is like human growth hormone, insulin, stuff that saves lives. And... But it's an invention, quote unquote. It is. I mean, like creating human growth hormone using E. coli to string together amino acids, that's an invention. Yeah. Hats off to you. Sure. So what's the controversy? What's the problem with gene patents? with issuing 20 years of exclusivity to somebody who teaches E. coli to string together amino acids?
Well, there's a couple of different controversies. One, the ethical and social and economic. The other is the legal. As far as legal goes, if you're against it, you're going to argue that, dude, these are your genes. There is nothing more natural than the genes in your body. So, of course, you can't patent them. And it doesn't matter what you do to them. like it's still based on this product of nature. Yeah. That just leave it alone. Like this should be, this is the heritage of humankind. Yeah. It's us. It's what makes us us. Of course we shouldn't be issuing patents to corporations. On genes.
Yeah. Say the critics of gene patents. Right. Proponents would say, hey, dude, if we can extract this from the body and manipulate it many times to the point where it's not even the same as before, then of course you should be able to patent that. Right, and that's one of the reasons why we have patents is to reward innovation, to reward very smart people and to encourage more innovation and research and things that save lives. So you don't have to extract growth hormone from the pituitary glands of the dead. Myriad Genetics, should we talk about that? It's a good example. This is a big one. They filed seven patents relating to RCA1 and BRCA2.
basically what they developed was a test kit for breast and ovarian cancer. Right. And these two genes account for, I think, like 15% of breast or ovarian cancer. I think breast cancer. Right. So it's pretty substantial. And Myriad got a patent on the screening kit that they created. And they promptly turned around and sent letters to just about every cancer screening laboratory in the world. Right. and said, hey, we hear that you guys are saving people's lives. That's awesome. Keep up the good work. Just make sure that you send all of your cancer screening when it relates to these two genes to us.
And we'll do it, and we're going to charge you for it. Right. And throughout the world, people in laboratories threw these letters up in the air and clucked their tongues and stroked their beards in anger and strutted about their flasks. And in Canada, it was just overtly ignored. The Canadian government itself stepped in and was like, you don't need to listen to these crackpots. In Europe, it was very controversial. I think it's largely ignored. So it's upheld, I think, in the U.S. because this was the country that issued the patent. But elsewhere, they're like, we're not listening to you. And for a long time, Myriad didn't do anything.
There wasn't any lawsuits. Right. And then there was one. And in 2010, the company – It was turned down. Yeah, well, the U.S. District Court said, no, we're not going to support this. And then in 2011, Court of Appeal for the Federal Circuit overturned that lower court's decision. So it went up one step higher, and myriad got satisfaction. They got myriad satisfaction. Yeah, do you know that means 30,000? It's an actual number. Myriad? Yeah, just like decimated as 10%. Right. But this is one that I'm on the side of people using it correctly, because I can't stand it when someone says, like, I had a myriad of.
Yeah. When it's supposed to be. Just myriad. I had 30,000 coughs. See, that's where I disagree with the 30,000 part. Yeah. Like, say it correctly, but come on. Or you could just say, like, I had a myriad of coughs and then wink after. Like, I don't know what I'm talking about. I'm just using it a different way. Pull my finger. Yeah. So the myriad case continues. I did like when it was initially ruled against the ruling judge. He sounded sort of like a... Who was Andy Griffith's judge character? Or no, lawyer character? Matlock. Matlock. That's a lawyer's trick, is what he called it. Yeah, quote, lawyer's trick.
The Supreme Court said, no, it's not a trick. They modified it. Your Honor, I don't know spit about lawyering. But I do know the human heart. Yeah. I never saw that show. I didn't either, but there was a good Saturday Night Live. send up of it. Of course it was. Phil Hartman did. R.I.P. Phil Hartman. Yeah. So ethical social challenges and controversies. This is where it gets hot. Yeah, and I guess we should say, like, we just kind of left it, like, myriads up in the air. That's the standard for what's going on in the U.S. right now as far as gene patents go. And that was just a few months ago.
The patent office is honoring its obligations, and then the courts are, people are suing people, and the courts are just going all over the place. So it's just totally up in the air whether or not this is going to be allowed or what kind of standards we'll eventually adopt. We're in the heat of this. Yeah, we are. So, yeah, let's talk about ethical, the ethics of this, right? Yeah, I mean, it's sort of along the same lines in a way as the legal challenges because proponents are going to say, you know, this is great for research. if you don't allow this, then companies aren't going to be able to make a profit from this, so there's going to be no incentive to continue this kind of research.
Research is going to stop. And this research is important. You can say what you will about Myriad, but their screening test saves lives, right? Yeah, absolutely. And if they invented it, then this sort of breaks down almost into private sector capitalism versus, because if the private sector dried up because they couldn't make any money off this stuff, all the research would be left to government-funded laboratories, right? Oh, yeah. It's very much divided among capitalist socialist lines. And I think, though, that people who normally wouldn't consider themselves socialist are falling into the critics' camp.
Yeah. Just the idea of having Gene Patton's out there, It is something that I think a lot of people think should just belong to all humankind. But the free market proponents do make a pretty good case that if you don't reward innovation and invention and clever techniques monetarily, then you have a problem. On the other side, though, you can say, well, you're also issuing monopolies on things that are life-saving, that a company can charge whatever they want. Like, what will you pay to find out whether you have cancer? Right, right. Or what will you pay for a drug that will get rid of your cancer, you, Chuck Bryant?
Because we know your genetic makeup, and we know that this will work perfectly with your genetic makeup. How much will you pay for that? And we're the only company you can get it from. I'd pay everything I had. Yes, you would. And so would every other person who had the same or similar genetic makeup as you, which is problematic. Yeah, it is. And also, if it cures your cancer, but then three weeks later your head explodes, but it doesn't happen in everybody, that company has zero incentive to make its product so that it doesn't make 30% of people's heads explode. Right. Because it has a monopoly.
What are you going to do? You're still going to buy this thing. Yeah. Right? Another argument for is that at least what this process does is creates transparency in research. Yeah. It's all out there. Everybody knows. People might not be wasting their time duplicating research, A. Yeah, that's a big one. And B, people can build on your research, and it will propel it further into the future. It should. Pretty good argument there. Yeah, but you can understand why this is not a cut-and-dried argument. Well, the AMA says we know likey. Yeah, the AMA is saying that this won't help support research, the American Medical Association.
It's saying that it will inhibit research on genetic disease. And basically, even worse than that, it will inhibit access for the average person. So I want to give an example of what is at stake here, okay? Yes. So we've kind of seen like this kind of reward does propel innovation and research, right? Yes. But there's this with the Plant Act of 1930 that allowed people to genetically modify plants. Luther Burbank. Yeah. And then get patents for those. There's a company called Monsanto, and Monsanto came up with this idea called genetic use restriction technology. It's also known as terminator technology, where they have figured out how to insert a gene, basically a suicide gene, into its seeds.
It's genetically modified seeds, right? For second gen seeds. Yes. So for the first generation seed, your plant will just grow like normal, like a normal genetically modified organism, right? Yeah. And it will produce seeds. Yeah. But those seeds it produces are sterile because it has a gene in it that won't allow it to produce seeds that can be used again. This means that you have to go to Monsanto to buy their seeds. You can't hoard their seeds and replant next year. Every year you have to go and buy their seeds. Right. This is fine and dandy for very wealthy farmers in the West, but no matter where you are in the world, if you want to grow this cricket-resistant type of wheat that Monsanto owns a patent on, you've got to buy it from Monsanto, and you have to buy it every year, no matter what you can afford or can't.
And basically there's a really good argument that you should not be allowed to own a patent, a license, on a process as natural as a plant producing offspring, producing seeds. Right. So that's one example that a lot of people point to is like a cautionary tale against gene patents. They did not. Monsanto did not. They still hold this. They didn't release it and say this is what we're doing. No, they actually vowed to not do that. Yeah, they said, we won't do it, but you've got to sign this agreement if you do business with us, or we'll start releasing this. Right, and the agreement says that you won't reuse seeds that you get from their genetically modified plants.
And didn't they buy up the company that was originally Delta and Pineland Company? Mm-hmm. They ended up buying them up, didn't they? Yes, and this company has vowed the opposite, that they're going to start using that Terminator gene commercially. Oh, they have? Yeah. So a lot of people are very nervous about whether or not that genetic use restriction technology will come into play. But, I mean, it's already effectively in play. We should do a Monsanto podcast. That would be explosive. That would be very explosive. Yeah, we will. So that's Gene Patents. We haven't done one of these in a while.
I'm quite sure we're going to hear from people on both sides of this issue. And we want to. Yeah, I think we did a good job this time of keeping our own dirty laundry out of it. Yes, we did. Kudos to you, buddy. And you. So we have a bunch of stuff on jeans and jean patents on HowStuffWorks.com. Just type in jean patents. It'll bring up a lot of stuff, including a quiz, which you could say is maybe a compendium to this episode. Who wrote this one? Michael Franco? Really? I don't recognize the name. Yeah, he does everything. He does. But yeah, it was a pretty good article. Just type in Gene Patton said the search bar at HowStuffWorks.
com. Also, don't forget, check out The Corporation. It's just a really interesting documentary. And I said search bar in there somewhere, so that means it's time for listener mail. And this is the winning listener mail. Is it? It's the first one. Really? Yeah. that John Hodgman promised a book to? Yep. The author of this email will receive a free copy, hardcover copy, of John Hodgman's incredible book about the end of the world, the third in his trilogy of knowledge, world knowledge, called That Is All, which just came out on November 1st. Hot off the presses. And you really should buy it. Yeah, except for this person.
John's a buddy and stuff, but it's a very, very fun book. Yeah, it is. All right. I kind of forgot that when I picked this, but I think this Turkish listener, he deserves it. So, yeah, we'll go with him. The lucky Turk. The lucky Turk. Hey, guys, listening to you from Turkey. I guess I gave that away. I really love the podcast. Thanks a lot for what you're doing. This might sound a bit like complaining, though. No, wait, wait, wait. I prefer that I don't come across as complaining, and I don't know if you even have any more listeners from Turkey. But in various episodes, every time you mention Turkey, like when somebody was stuck in Turkey on the last episode where you were wondering if people can surf on the Bosphorus.
Bosphorus. Bosphorus. It always kind of sounds like you look down on Turkey a bit, to be honest. That is untrue. Now, we talked about being stuck in Turkey and how awful that would be. I don't recall that because I would love to go to Turkey sometime. I have a friend who played bass in the second most popular Turkish rock band in the late 90s. Really? Yeah, I don't remember the name of it, but Pepsi did a poll of Turks and my friend's band came in second in the most popular. Was your friend Turkish? No, he went to Turkey just for the heck of it and ended up in the number two most popular rock band in Turkey.
That's probably not hard to do. See, that's what this guy's talking about right there. Yes, I know, I know. That's you, Chuck. I'm getting wrapped up in your problems. All right. Sorry to drag you down. You guys seem to be a couple of people who would like to know the facts, so I just wanted to suggest you check out things like Olu Denez Turkey or maybe Fefe Turkey or Bodrum Turkey in Google Images. I'm just saying, I don't think anyone would mind being stuck in Turkey, really, if you really know what Turkey was like. And I did look these places up. Are they amazing? Oh, dude. You know, Turkey also arguably has the world's first city.
I can't remember what it's called, but it's old. Just because I felt like I have to say this since I'm already writing an email, there is no surfing on the Bosporus, not even swimming on the Bosporus. It's kind of dangerous. Usually it's just bigger ships crossing country that use that, and there are no beaches there. But Turkey is surrounded on three sides by the sea. It's basically a peninsula. So there's windsurfing, every kind of water sport you can think of, on the seaside cities. In the media, Turkey comes across as if it was a dusty, hot, and primitive country, which I think is what I had been saying.
And I should say, when I worked for my last company, which was a chicken software company, one of our clients was in Turkey, and some of our guys would go over there to the chicken farms. It was awful, dude. They would come back saying, please, God, don't ever send me to Turkey again. Because they were in the awful part of Turkey. They were raising chickens in Turkey? Yeah, yeah. I have to say that, though, only some small cities on the eastern edges are like that, guys. The people in different clothes are more interesting than people to look at who look like most of us who look like every other European country.
So the media only reflects the different part. Kind of like only showing rednecks grilling steak on a shopping cart, which I've never seen. Is that a new thing? I guess so. I would like to see that. The rest of Turkey is pretty much like California. Great climate, people, social and culturally even. Especially Istanbul, it resembles a very crowded San Francisco. Not Constantinople. What, with all the hills and the bridges and the hipsters. So that is from Gozde, G-O-Z-D-E. And, dude, you're getting a book. And I am sorry for bad-mouthing turkey because I did look at pictures and it's nothing at all like I thought.
I'm not sorry for bad-mouthing turkey because I didn't. I didn't. And if I did, I was totally joking. Then I feel like I owe this guy a book. Yeah. The only place in the world I would never go is Detroit. I totally go to Turkey. Detroit's awesome. So what's his name? Gozda, you get a book, so you're going to have to write back in. Yeah, we need your mailing address, Gozda. Yeah. And we should probably make them pay the difference for international shipping. Well, and it's Turkey. It probably just says Gozda Turkey. That's his address. Yeah. Because there's only... Do they even have addresses there?
We'll just put a bunch of stamps on it and throw it in the water. Exactly. Go to us. Send us an email with your mailing address because we really think there probably are more than one of you in Turkey. And to all the rest of you who send in emails, thank you. We'll try to read them, but you get no books. If you want to get in touch with us, you can on Twitter, SYSK Podcast, on Facebook, facebook.com slash stuffyoushouldknow, and via email at stuffpodcast at howstuffworks.com. Be sure to check out our new video podcast, Stuff from the Future. Join HowStuffWorks staff as we explore the most promising and perplexing possibilities of tomorrow.
Brought to you by the reinvented 2012 Camry. It's ready. Are you? Living with an autoimmune condition isn't easy, and every journey is different. That's why Season 5 of Untold Stories, Life with a Severe Autoimmune Condition, from Ruby Studio and Argenix, shares powerful firsthand stories from people with conditions like MG and CIDP. Hosted by Martine Hackett, these conversations dive into what resilience really looks like through setbacks, breakthroughs, and finding strength in community. Listen on the iHeartRadio app, Apple Podcasts, or wherever you get your podcasts. Attention parents and grandparents.
If you're looking for a gift that's more than just a toy, give them something that inspires confidence and adventure all year long. Give them a Guardian bike, the easiest, safest, and number one kid's bike on the market. Yeah, with USA-made kid's specific frames and patented safety technology, kids are learning to ride in just one day with no training wheels needed. It's why Guardian is America's favorite kid's bike and the New York Times and Wirecutter's top pick three years in a row. That's right. My daughter has a Guardian bike, and she loves it, and that thing was really easy to put together.
And get this. This holiday season, Guardian is offering their biggest deal of the year, over 40% in savings on all bikes, plus $100 in free accessories. Guardian bikes have become one of the most sought-after gifts of the season, and inventory is going fast, so don't wait. Join over a half a million families who've discovered the magic of Guardian. Visit guardianbikes.com to shop now. This is an iHeart Podcast. Guaranteed Human